Alexander & Baldwin Inc SEC Filings

A shareholder of ALEX filed a Form 144 notice to sell up to 700 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $14,595.00 and a stated sale date of 12/10/2025. The issuer has 72,758,460 shares outstanding; this is a baseline figure, not the amount being sold. The 700 shares were acquired from the issuer on 02/01/2023 as compensation.

Over the past three months, the same selling account, The Meredith J Ching Revocable Living Trust, sold three separate blocks of 700 common shares each, on 09/10/2025, 10/10/2025, and 11/10/2025, generating gross proceeds of $13,128.78, $11,728.57, and $10,837.33, respectively.

Alexander & Baldwin, Inc. agreed to be acquired by Tropic Purchaser LLC, a joint venture of MW Group, Blackstone Real Estate funds and DivcoWest, through a merger in which the company will become a wholly owned subsidiary and its common stock will cease to exist as a public listing.

Each outstanding share will be converted into the right to receive $21.20 in cash, without interest, with this amount reduced to reflect a previously approved $0.35 per share fourth-quarter 2025 dividend payable on January 8, 2026. All RSU and PSU awards will be cancelled and exchanged for cash amounts based on the merger consideration and existing vesting terms, while director RSUs will be cashed out at the same per-share price.

Closing requires approval by a majority of outstanding shares, absence of blocking legal orders and no Company Material Adverse Effect, and is not subject to any financing condition. Blackstone Real Estate Partners X L.P. committed $2.15 billion of equity financing and guaranteed up to $155,300,000 of reverse termination and related amounts, while the company agreed to pay a termination fee of $50,500,000 or, in certain qualified competing-offer scenarios by set January 2026 dates, $25,250,000.

Alexander & Baldwin (ALEX) reported an insider transaction by an executive officer. Exec. VP, External Affairs Meredith J. Ching sold 700 shares of common stock on 11/10/2025 at a weighted average price of $15.4819 per share, coded as an open-market sale (S) under a Rule 10b5-1 trading plan. The filing notes the sales occurred in multiple trades between $15.41 and $15.54.

Following the transaction, reported beneficial ownership stands at 146,149 shares held directly, plus 213 shares held indirectly by spouse, and 781.571 shares held indirectly via TCESOP.

Alexander & Baldwin (ALEX) filed a Form 144 notice for a proposed sale of 700 common shares through UBS Financial Services, with an aggregate market value of $10,864.00. The filing lists an approximate sale date of 11/10/2025 on the NYSE.

The shares to be sold were acquired as compensation on 02/01/2023. The filing also reports recent sales by The Meredith J Ching Revocable Living Trust: 700 shares on 08/11/2025 for $12,700.80, 700 shares on 09/10/2025 for $13,128.78, and 700 shares on 10/10/2025 for $11,728.57. Shares outstanding were 72,758,460 as of the filing’s reference line.

This is a notice of intent to sell under Rule 144; actual sales and timing depend on market conditions and applicable Rule 144 limits.

Alexander & Baldwin, Inc. amended its revolving credit agreement and created a new term loan facility with total commitments of $200 million. The company immediately borrowed the full $200 million on November 3, 2025 and repaid the outstanding revolving credit balance of $191 million plus accrued interest.

The new term loan allows up to three borrowings through May 3, 2026 and carries a maturity of November 3, 2030. Pricing grids were updated to include the term loan rates, and the prior 0.10% SOFR adjustment was removed. As of closing, the term loan rate was 1‑month Term SOFR + 1.15% under the financials-based grid.

To manage interest costs, the company entered a new $70 million swap fixing at 4.57% (inclusive of the 1.15% applicable rate) and reassigned existing $73 million and $57 million swaps (weighted average 4.76%) to the term loan. Together, the $200 million borrowing is swapped to a 4.69% weighted average fixed rate through maturity.

Alexander & Baldwin (ALEX) reported Q3 2025 results with total revenue of $50.2 million versus $61.9 million a year ago, as Land Operations activity tapered. Commercial Real Estate remained steady at $50.2 million (from $49.4 million). Operating income was $19.2 million (vs. $22.1 million), and net income was $14.3 million, or $0.20 per diluted share (vs. $0.26).

Year to date, revenue was $155.7 million (vs. $174.2 million) and net income rose to $60.9 million (vs. $48.1 million), aided by $18.4 million in gains and settlements. The company recognized $2.6 million selling profit in Q3 from sales‑type leases tied to a Kaka‘ako Commerce Center option exercise, and ended the quarter with $23.7 million of investments in sales‑type leases, net.

Cash was $17.3 million, debt (carrying value) was $475.2 million, and the revolver balance was $183.0 million. A June Termination Agreement created a refund liability; the balance was $45.3 million at quarter‑end after a $10.0 million payment. Shares outstanding were 72,758,460 as of September 30, 2025.

Alexander & Baldwin (ALEX) reported a routine disclosure, furnishing materials on October 30, 2025 that announce results of operations and financial condition for the three and nine months ended September 30, 2025. The press release is furnished as Exhibit 99.1.

The Company also made available a Supplemental Information document providing additional operating and financial details for the three and nine months ended September 30, 2025 and 2024, furnished as Exhibit 99.2. These materials were posted to the Company’s website and are provided for investor reference under Regulation FD.

Insider sale under 10b5-1 plan. An executive officer, Meredith J. Ching, reported the sale of 700 shares of Alexander & Baldwin, Inc. (ALEX) on 10/10/2025 at a weighted average price of $16.7551 per share. After the sale Ms. Ching beneficially owned 146,849 shares directly, plus 213 shares held by a spouse and 781.571 shares held indirectly through the TCESOP. The filing states the sales were executed pursuant to a Rule 10b5-1 trading plan and that shares were sold in multiple transactions at prices ranging from $16.65 to $17.00. The report is a routine Section 16 disclosure showing a planned, pre-arranged disposition rather than an ad hoc trade.

Notice of proposed sale under Rule 144 for Common stock. The filing shows an intended sale of 700 shares through UBS Financial Services, Inc. with an aggregate market value of $11,900.00. The filer reports acquiring the shares on 02/01/2023 as compensation from the issuer and indicates prior sales of 700 shares each on 07/10/2025, 08/11/2025, and 09/10/2025 with gross proceeds of $12,552.05, $12,700.80, and $13,128.78, respectively. The filing lists 72,753,270 shares outstanding and an approximate sale date of 10/10/2025. The signer affirms no undisclosed material adverse information and provides standard Rule 144 declarations.